Is duration of hospital participation in meaningful use associated with value in Medicare? by Brice, Yanick N & Joynt Maddox, Karen E
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
7-1-2019 
Is duration of hospital participation in meaningful use associated 
with value in Medicare? 
Yanick N. Brice 
Wayland, Massachusetts, USA 
Karen E. Joynt Maddox 
Washington University School of Medicine in St. Louis 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Recommended Citation 
Brice, Yanick N. and Joynt Maddox, Karen E., ,"Is duration of hospital participation in meaningful use 
associated with value in Medicare?." JAMIA Open.,. . (2019). 
https://digitalcommons.wustl.edu/open_access_pubs/9415 
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been 
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. 
For more information, please contact engeszer@wustl.edu. 
Research and Applications
Is duration of hospital participation in meaningful use
associated with value in Medicare?
Yanick N Brice1 and Karen E Joynt Maddox2
1Wayland, Massachusetts, USA and 2John T. Milliken Department of Medicine, Cardiovascular Division, Washington University
School of Medicine, St. Louis, Missouri, USA
Corresponding Author: Yanick N Brice, PhD, MPA, 153 Concord Road, Wayland, MA 01778, USA (ybrice@post.harvard.edu)
Received 6 September 2018; Revised 23 December 2018; Editorial Decision 31 January 2019; Accepted 8 February 2019
ABSTRACT
Objectives: “Meaningful Use” (MU) of electronic health records (EHRs) is a measure used by Medicare to deter-
mine whether hospitals are comprehensively using electronic tools. Whether hospitals’ engagement in value-
based initiatives such as MU is associated with value—defined as high quality and low costs—is unknown. Our
objectives were to describe hospital participation in MU, and determine whether duration of participation is as-
sociated with value.
Materials and Methods: We linked national Medicare data with MU and other hospital-level and market data.
We analyzed bivariate relationships to characterize duration of participation. We estimated inverse probability-
weighted multilevel logistic regressions to evaluate whether duration of participation was associated with
higher likelihood of value—operationalized as having performance on 30-day readmission and inpatient spend-
ing at or below the national average.
Results: Of 2860 short-term hospitals, 59% had 4 or 5 years of MU participation by 2015; 7% had 1 or 2 years.
There were differences by duration of participation across location, ownership, and size. Seventeen percent of
hospitals were classified as high-value. Controlling for hospital characteristics, and holding constant market lo-
cation, there was no evidence of a statistical association between duration of participation and value (odds ratio
¼ 1.05, 95% confidence interval: 0.91–1.21; P¼ .51). Examining the 2 outcomes separately, there was a signifi-
cant relationship between duration of participation and lower Medicare inpatient spending, but not 30-day read-
mission.
Discussion: Sustained participation in MU is associated with lower Medicare spending, but not with lower read-
mission rates.
Conclusion: Policy interventions aimed at increasing value may need a broader focus than EHR implementation
and use.
Key words: Meaningful Use of electronic health records, health information technology, value in Medicare, 30-day hospital read-
mission, Medicare inpatient spending
BACKGROUND AND SIGNIFICANCE
The United States health care system has exceptionally high spend-
ing,1–3 but underperforms on many health indicators, such as life ex-
pectancy,4 and maternal mortality.5 With projected growth rates
averaging 5.5% a year, health spending is expected to account for
19.7% of the nation’s gross domestic product by 2026.6 Therefore,
there is growing interest in quantifying and ultimately incentivizing
the “value” of health care, that is, the outcomes achieved as a func-
tion of dollars spent.
Many proponents believe that electronic health records (EHRs)
have the potential to increase value by transforming health care de-
livery, reducing health spending, and improving quality.7–11
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Consequently, the Centers for Medicare and Medicaid Services
(CMS) launched the Meaningful Use (MU) of EHRs Incentive Pro-
gram in 2011. The MU Program is a pay-for-performance initiative,
designed to accelerate adoption and use of certified EHRs.10,12–14
The initiative was initially voluntary. However, as of 2015, eligible
providers faced payment reductions for noncompliance with MU
requirements.10,15 The MU requirements consist of quantitative and
qualitative criteria targeting quality, safety, efficiency, care coordi-
nation, patient and family engagement, reduction in health dispar-
ities, and other public health objectives.12,16,17 The MU initiative
was designed to be implemented in 3 stages: Stage 1 emphasized
capturing and sharing patient data efficiently; Stage 2, which started
in 2014, focused on using the EHR to support quality improvement
(QI) and information exchange; and Stage 3 targets improved
outcomes.18
In response to the financial incentives authorized under
MU,12,13,19 adoption and use of EHRs has increased among eligible
providers.20–23 However, evidence on the impact of MU of EHRs on
outcomes and costs has been mixed.24–28 For example, studies have
shown that MU is related to improvements in patient satisfaction
and adherence to process of care indicators,29 and to a reduction in
disparities in 30-day readmissions among African-American Medi-
care beneficiaries,26 but such reduction has not been demonstrated
within the broader Medicare population,24–26 nor systematically ob-
served across clinical conditions.30
One reason for these limited findings may be the fact that the ini-
tial years of the MU initiative mainly focused on data capture.
Hence, it may simply have been premature to assess program perfor-
mance. Additionally, prior studies have not specifically examined
the duration of a hospital’s participation in MU, which may repre-
sent continued growth and experience. Finally, few studies have
evaluated comprehensive outcomes that summarize both quality and
costs of care, notably “value”, a concept that is of increasing impor-
tance in today’s policy environment and consistent with current defi-
nitions from the National Quality Forum and others.31
OBJECTIVES
In this study, we therefore had 2 objectives: first, to describe hospital
participation in MU; and second, to determine whether duration of
MU participation is associated with value—defined as high quality
and low costs—from the perspective of Medicare. We operational-
ized value as simultaneously having performance levels, at or below
the national average, on the 2 broadest measures currently in use in
Medicare’s public reporting and value-based payment programs: 30-
day hospital-wide all-cause unplanned readmission (HWR) and
Medicare inpatient spending.32 We hypothesized that, among hospi-
tals with successful MU attestations, sustained participation is asso-
ciated with higher likelihood of value.
MATERIALS AND METHODS
Study overview
We used a cross-sectional design to describe hospital participation in
the Medicare EHR Incentive Program, and to evaluate whether du-
ration of participation was associated with higher likelihood of
value, assessed from the perspective of Medicare. To remove the in-
fluence of group differences that could obscure unconfounded de-
scriptive comparisons among hospitals, we additionally adjusted for
hospital-level covariates, including accreditation status,
organizational characteristics (eg, ownership status and size), and
patients served (eg, illness severity) in multilevel logistic regressions,
weighted by the inverse of the propensity scores for early participa-
tion in MU.
Sample and data sources
We linked publicly available national Medicare data on short-term
acute care hospitals, profiled on both 30-day readmission and Medi-
care inpatient spending, with MU data and other hospital-level and
market data. We obtained these data from various CMS data sour-
ces, including the Hospital Compare Website; the Provider of Serv-
ices File (2015); and the Impact File (2015). We extracted data for
hospital participation in the Medicare EHR Incentive Program from
the Office of the National Coordinator for Health IT’s (ONC) Web-
site. We limited our sample to only those hospitals with at least 1
year of MU attestation as well as available information on quality
and costs (outlined below). We also used the Dartmouth Atlas of
Health Care (2014) to match hospitals with their respective market
area, represented by hospital referral region, to account for hospital
clustering into health care markets.
Measures
Outcomes
We obtained performance data on risk-standardized 30-day HWR,
from Hospital Compare, for the period covering July 01, 2015 to
June 30, 2016. The HWR measure is publicly reported and broadly
used to assess the quality of hospital care delivered to Medicare ben-
eficiaries aged 65 and older. It represents over 55% of Medicare
hospital payments across 5 clinical cohorts, including surgery/gyne-
cology, general medicine, cardiorespiratory, cardiovascular, and
neurology.33
We also obtained Medicare spending data from Hospital Com-
pare. Using the October 2017 update of the Medicare Spending Per
Beneficiary (MSPB) Spending Breakdowns by Claim Type File, we
extracted Medicare spending per hospitalization episode for the per-
formance period covering January 01, 2015 to December 31, 2015.
The MSPB measure aggregates all Part A and B claims, including in-
patient spending and any spending incurred 3 days prior to hospital-
ization, as well as spending in the 30 days following discharge.34
However, we focused here on the inpatient component, because it is
the most direct measure of hospital efficiency, and is not impacted
by our other measure, readmission. The MSPB measure is price-
standardized to remove differential payments to hospitals associated
with (a) regional labor costs and hospital wage index; and (b) dis-
proportionate share hospital (DSH) and indirect medical
education.35
We classified all hospitals having both HWR and Medicare inpa-
tient spending per hospitalization episode falling at or below the na-
tional average as high-value hospitals. The response variable of
interest is binary, coded as 1 for high-value hospitals and 0
otherwise.
Exposure
We obtained the July 2017 update of the EHR products used for
MU Attestation public use file, from the ONC Website, to extract
data on hospital patterns of participation in MU. We focused on the
variable called payment year to identify the number of successful
MU attestations from program inception in 2011 through 2015.
Payment year has integer values 1–5. Given that hospitals attest to
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MU only once during any performance period, this effectively cap-
tures the duration of MU participation, treated as an interval scale.
Covariates
We extracted other hospital-level data on accreditation status, orga-
nizational characteristics, and patients served to adjust for potential
group differences. We accounted for accreditation status by the Joint
Commission (JC) because earning such recognition provides hospi-
tals access to resources that can strengthen their QI efforts. More-
over, JC accreditation has been associated with higher health
information technology adoption.36 Similarly, we accounted for
hospital location (urban/rural), teaching mission, ownership (not-
for-profit/public/for-profit), and size (small/medium/large). These
characteristics have been linked with the individual component out-
comes, and/or adoption and use of EHRs in previous work.20,36–39
Lastly, we accounted for hospitals’ case mix index (the average
diagnosis-related group [DRG] weight for inpatient discharges,
which reflects average severity of illness), and their burden of caring
for the uninsured and patients dually eligible for Medicare and Med-
icaid, as reflected by the DSH percentile. These characteristics have
previously been identified as predictors of resource use.40
Analytic approach
We computed descriptive statistics for key hospital characteristics
and examined bivariate relationships to characterize MU participa-
tion. To test our hypothesis relating duration of participation to
value in Medicare, we specified a dose-response model, including a
linear term in duration of participation and covariates. As it is cus-
tomary in multilevel modeling, we built a series of models of increas-
ing complexity,41 including variables forming a coherent group one
at a time.42 To facilitate interpretation of the intercept,41,42 we
transformed the MU exposure by subtracting the constant 2 from
the original metric. Rescaling the MU exposure using 2 allows a rel-
evant zero point, corresponding to the early years of the program,
that is, MU Stage 1. We transformed continuous variables into quar-
tiles to reduce the influence of outliers and set the highest quartiles
as the reference categories. We dummy-coded all categorical varia-
bles and set reference categories as indicated in the results.
Given that the primary outcome is binary, and hospitals are clus-
tered into markets, we used a generalized linear mixed model, with
a binomial distribution and a logit link, for model estimation. We
assessed model fit for each group of variables, as noted above, using
the Bayesian Information Criterion procedure.43 We tested statisti-
cal significance of individual parameters using Wald-type tests and
set the significance level at a 5% threshold. Our final model in-
cluded all main effects and a random intercept. We used robust stan-
dard errors to adjust for hospital clustering into markets and the use
of inverse probability weights, which account for unequal probabil-
ity of participation in MU of EHRs when programs first started in
2011 (see Supplementary Material).
We conducted additional sensitivity analyses in which we
substituted a measure of postoperative mortality for the readmission
measure in order to identify high-value hospitals. While mortality is
a somewhat more difficult concept to examine in relation to costs
(because patients who die are often either highly expensive, if their
course is prolonged, or very inexpensive, if their course is brief), we
saw this as a way to determine if our findings were robust to our
choice of clinical outcome. We used R software and the SAS statisti-
cal package for the analyses.44,45 Because all data were public and
de-identified, the study met the criteria for exemption from review
by the Brown University Institutional Review Board.
RESULTS
Hospital characteristics and participation in MU
Our sample included 2860 short-term, acute care hospitals. Of these
hospitals, 82% were accredited, and 73% were located in an urban
area. Nearly 1/3 had a teaching mission (34%), were either of public
(16%) or for-profit ownership (23%), or small in size (29%). Hospi-
tals’ average case mix index was 1.57, indicating moderate complex-
ity (Table 1).
Most hospitals had 4 years (39.3%) or 5 years (20.0%) of MU
attestation by 2015 (Table 1). Only a small number had 1 year
(2.3%) or 2 years (4.8%) In bivariate analyses, we found differences
among hospitals by duration of MU participation. For example,
not-for-profit hospitals were more likely to participate for 4 or 5
years, compared with public or for-profit hospitals (61% vs 57%
and 57%, respectively, P¼ .017; Table 1). Small hospitals were less
likely to participate for 4 or 5 years, compared with medium or large
hospitals (54% vs 60% and 64%, respectively, P¼ .031).
Hospital performance on 30-day readmission and
Medicare inpatient spending
When we examined the component measures of value, we found
variation in hospital performance on each. The mean 30-day HWR
rate was 15.3%, with range from 11.3% to 19.2%. Similarly, me-
dian Medicare inpatient spending per episode was $9906; the inter-
quartile range was $8517–$11 156.
In unadjusted multivariate weighted analyses, we found a statis-
tically significant, but very small relationship between duration of
participation and 30-day readmission rates (for each additional year
of MU participation, beta 0.04%, 95% confidence interval [CI]:
0.00–0.07%, P¼ .03; Table 2). However, in fully adjusted regres-
sions, this relationship was no longer significant (Table 3). Similarly,
unadjusted multivariate weighted analyses showed a significant as-
sociation of duration of MU participation with Medicare inpatient
spending (for each additional year of MU participation, beta
2.1%, 95% CI: 3.2% to 0.9%, P< .001; Table 2). Fully ad-
justed multilevel regressions demonstrated a slightly attenuated, but
still significant relationship (beta 1.6%, 95% CI 2.4% to
0.8%; P< .0001, Table 3). (Full regressions results are reported in
Supplementary Material.)
Predictors of hospital high-value status
Seventeen percent of hospitals were classified as high-value, having
performance levels on both the HWR and Medicare inpatient spend-
ing at or below the national average. Unadjusted analyses showed
no statistically significant differences in high-value status by dura-
tion of MU participation (for each additional year of MU participa-
tion, odds ratio [OR] ¼ 1.07, 95% CI: 0.93–1.22; P¼ .36, Table 2).
This relationship was minimally changed after full adjustment for
hospital-level covariates (OR ¼ 1.05, 95% CI: 0.91–1.21; P¼ .51,
Table 3).
However, a number of other hospital characteristics, beyond du-
ration of MU participation, were strongly related to value. For in-
stance, rural hospitals had higher odds of being classified as high-
value than urban hospitals (OR ¼ 1.44, 95% CI: 1.12–1.86;
P< .01; Supplementary Material). There were no significant differ-
ences based on teaching status, but for-profit hospitals had lower
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odds of being classified as high-value than not-for-profit hospitals
(OR ¼ 0.64, 95% CI: 0.47–0.88, P¼ .01). Small hospitals had
significantly higher odds than larger ones (OR ¼ 2.99, 95%
CI: 1.61–5.57; P< .01). Compared with hospitals serving the sickest
patients, hospitals in the first quartile of case mix (that is, those with
the healthiest patients, OR ¼ 15.7, 95% CI: 9.58–25.6; P< .0001)
Table 1. Hospital characteristics by stage and duration of participation in MU


















JC accredited 2343 (81.9) 2.4% 4.9% 32.7% 39.6% 20.4%
Not JC accredited 517 (18.1) 1.6% 4.5% 37.9% 37.9% 18.2%
Geography .003
Urban 2098 (73.4) 2.2% 5.1% 32.8% 38.2% 21.6%
Not urban 762 (26.6) 2.4% 3.9% 35.8% 42.4% 15.5%
Organizational characteristicsa
Medical school affiliation .059
No affiliation 1885 (65.9) 2.5% 4.7% 34.5% 38.7% 19.6%
Graduate/limited teaching 582 (20.4) 2.6% 5.8% 34.0% 39.2% 18.4%
Major teaching 393 (13.7) 0.8% 3.8% 29.0% 42.2% 24.2%
Ownership status .017
Not-for-profit 1754 (61.3) 2.6% 5.0% 31.8% 40.5% 20.1%
Public 462 (16.2) 1.1% 5.0% 36.6% 40.9% 16.5%
For-profit 644 (22.5) 2.2% 4.0% 36.7% 34.8% 22.4%
Hospital size .031
Small (<100 beds) 816 (28.5) 2.7% 5.6% 37.4% 36.6% 17.7%
Medium (100–399 beds) 1537 (53.7) 2.4% 4.6% 32.6% 40.0% 20.4%
Large (over 400 beds) 507 (17.7) 1.2% 3.9% 30.8% 41.6% 22.5%
Patients served
CMI 1.57 (0.34) 1.59 (0.31) 1.58 (0.41) 1.58 (0.37) 1.55 (0.30) 1.59 (0.31) .068
DSH patient 0.28 (0.17) 0.27 (0.19) 0.27 (0.16) 0.28 (0.17) 0.30 (0.17) 0.26 (0.15) <.0001
Note: Sum total may not add up to 100% due to rounding.
CMI: case mix index; DSH: disproportionate share hospital; JC: Joint Commission; MU: Meaningful Use; n/a: not applicable.
*P-values are reported for differences across groups.
aPercentages are reported for categorical variables.
bMean and (standard deviation) for continuous variables.
Table 2. Associations of duration of participation in MU with 30-day hospital-wide all-cause unplanned readmission, hospital inpatient
spending, and value in Medicare (unadjusted)a
30-Day hospital-wide readmission Hospital inpatient spendingb Value in Medicarec
Estimate (s.e.) (rates, %) 95% CI
Estimate (s.e.)
(log scale) 95% CI
Estimate (s.e.)
(logit scale)
Odds ratio (95% CI)
(odds ratio scale, expb)
Intercept 15.18*** (0.04) 15.10–15.26 9.242*** (0.011) 9.219–9.264 1.72*** (0.13)
Duration of MU
participation
0.04* (0.02) 0.00–0.07 0.021*** (0.006) 0.032 to 0.009 0.06 (0.07) 1.07 (0.93–1.22)
CI: confidence interval; MU: Meaningful Use; s.e.: standard error.
*, **, and *** indicate significance levels 5%, 1%, and <.01%, respectively.
aMultilevel weighted regressions with robust standard errors. Sample size: hospital (N¼ 2860); market (N¼ 304).
bEstimates expressed in log scale. Intercept, b0, is estimated spending for hospitals with 2 years of MU participation, holding constant market location:
$10 322 (obtained from exp[9.242]). Effect estimates are interpretable as proportional differences in the outcome. For estimate values close to 0, use (100b) to ob-
tain proportional change in spending; for values greater than 0.1, use [100(expb – 1)]. For example, holding market location constant, each additional year of MU
participation is associated with 2.1% reduction in spending; this translates into approximately a reduction of $217 (obtained from 2.1% [$10 322]).
cHigh-value hospitals have performance at or below the national average on both 30-day hospital-wide all-cause unplanned readmission (15.3%) and Medicare
inpatient spending ($9324). Intercept, b0, is predicted odds of value for hospitals with 2 years of MU participation, holding constant market location: .179, or
about 1–5 (obtained from exp[1.72]). On the probability scale, this translates into a probability of .152 (15.2%). Effect estimate: holding market location con-
stant, each additional year of MU participation is associated with a 7% increase in the predicted odds of value; however, this estimate is not statistically significant.
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and those in the second quartile of case mix (OR ¼ 7.09, 95%
CI: 4.34–11.6; P< .0001) had markedly higher odds of value. Hos-
pitals in the second and third quartiles of DSH index, indicating a
lower burden of caring for the poor, had higher odds of being classi-
fied as high-value.
Sensitivity analysis
In additional sensitivity analyses, in which we used 30-day mortality
for serious treatable complications after surgery as the quality com-
ponent for our measure of value, we again found no evidence of an
association of duration of participation in MU with value.
DISCUSSION
We conducted a cross-sectional study to characterize hospital partic-
ipation in the Medicare EHR Incentive Program, and to evaluate
whether duration of MU participation was associated with higher
likelihood of value in Medicare—operationalized as simultaneously
having performance levels on 30-day HWR and Medicare inpatient
spending per hospitalization episode falling at or below the national
average. We found that duration of MU participation varied by hos-
pital characteristics, but there was no evidence of a statistical associ-
ation between duration of MU participation and value.
Interestingly, there was a significant, modest relationship between
longer duration of participation and lower Medicare inpatient
spending, but not 30-day readmission. We also found that urban lo-
cation and hospital characteristics, including size, and having a less-
complex case mix, were associated with value.
Our findings pertaining to hospital participation in the Medicare
EHR Incentive Program are, in general, consistent with those of pre-
vious work on MU. For instance, we found that, compared with
large hospitals, small hospitals were less likely to participate for 4 or
5 years. This adds to prior findings from an evaluation of the first
18 months of MU, which reported that small hospitals were
less likely to qualify for incentives than their large counterparts.20
Table 3. Predictors of 30-day hospital-wide all-cause unplanned readmission, hospital inpatient spending, and value in Medicarea
30-Day hospital-wide readmission Hospital inpatient spendingb Value in Medicarec
Estimate (s.e.)
(rates, %) 95% CI
Estimate (s.e.)







Intercept 15.27*** (0.08) 15.10–15.43 9.432*** (0.015) 9.403–9.461 4.38*** (0.40)
Duration of MU participation 0.03 (0.02) 0.00–0.06 0.016*** (0.004) 0.024 to 0.008 0.05 (0.07) 1.05 (0.91–1.21)
Organizational characteristics
Ownership status
Not-for-profit Reference Reference Reference
Public 0.05 (0.04) 0.02 to 0.13 0.013 (0.008) 0.029 to 0.003 0.08 (0.15) 1.08 (0.80–1.46)
For-profit 0.27*** (0.04) 0.19–0.35 0.037*** (0.008) 0.021–0.053 0.45** (0.16) 0.64 (0.47–0.88)
Size
Small (<100 beds) 0.31*** (0.07) 0.44 to 0.17 0.025* (0.012) 0.003–0.048 1.10** (0.32) 2.99 (1.61–5.57)
Medium (100–399 beds) 0.15** (0.05) 0.25 to 0.05 0.001 (0.008) 0.015 to 0.016 0.39 (0.29) 1.48 (0.83–2.61)
Large (over 400 beds) Reference Reference Reference
Patients served
Case mix index
Quartile 1 0.43*** (0.06) 0.30–0.55 0.484*** (0.013) 0.511 to 0.458 2.75*** (0.25) 15.66 (9.58–25.62)
Quartile 2 0.32*** (0.06) 0.21–0.44 0.284*** (0.010) 0.304 to 0.265 1.96*** (0.25) 7.09 (4.34–11.59)
Quartile 3 0.22*** (0.05) 0.11–0.32 0.183*** (0.009) 0.199 to 0.166 0.52 (0.28) 1.68 (0.98–2.90)
Quartile 4 (sickest) Reference Reference Reference
DSH patient
Quartile 1 0.38*** (0.05) 0.48 to 0.28 0.045*** (0.011) 0.024–0.065 0.26 (0.18) 1.29 (0.90–1.86)
Quartile 2 0.25*** (0.05) 0.34 to 0.15 0.007 (0.008) 0.009 to 0.024 0.35* (0.16) 1.41 (1.03–1.95)
Quartile 3 0.20*** (0.05) 0.29 to 0.11 0.006 (0.008) 0.011 to 0.022 0.36* (0.16) 1.43 (1.03–1.97)
Quartile 4 (neediest) Reference Reference Reference
CI: confidence interval; DSH: disproportionate share hospital; MU: Meaningful Use; s.e.: standard error.
*, **, and *** indicate significance levels 5%, 1%, and <.01%, respectively.
aMultilevel weighted regressions with robust standard errors. Sample size: hospital (N¼ 2860); market (N¼ 304). Full results are reported in Supplementary
Material.
bEstimates expressed in log scale. Intercept, b0, is estimated spending for hospitals with 2 years of MU participation, with reference categories (not accredited,
urban, nonteaching, not-for-profit, large, sickest and neediest patients), holding constant market location: $12 481 (obtained from exp[9.432]). Effect estimates are
interpretable as proportional differences in the outcome. For estimate values close to 0, use (100b) to obtain proportional change in spending; for values greater
than 0.1, use [100(expb – 1)]. Holding constant market location, and controlling for hospital characteristics, each additional year of MU is associated with a
1.6% reduction in spending; this translates into approximately a reduction of $200 (obtained from 1.6% [$12 481]).
cHigh-value hospitals have performance at or below the national average on both 30-day hospital-wide all-cause unplanned readmission (15.3%) and Medicare
inpatient spending ($9324). Intercept, b0, is predicted odds of value for hospitals with 2 years of MU participation, with reference categories as noted above, hold-
ing constant market location: .0128, or about 1–100; this translates into a probability of .0126 (1.3%). Effect estimate: Holding market location constant, and
controlling for hospital characteristics, each additional year of MU participation is associated with a 5% increase in the predicted odds of value; however, this es-
timate is not statistically significant.
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Moreover, just as reported by the same evaluation, we found differ-
ences in MU participation by hospital ownership status, with not-
for-profit hospitals leading in participating for the longest duration.
Sustained participation in MU is not related to value. Our
“value” measure is comprised of an outcome component (read-
mission) and a cost component (inpatient spending). There was no
significant relationship between MU and the readmission compo-
nent itself as a continuous outcome—despite good theoretical under-
pinnings for MU’s plausible impact on this outcome. There is
evidence supporting that nearly half of all readmissions are linked
with indicators of substandard care during the index hospitalization,
notably unresolved issues or inappropriate therapy at discharge, in
addition to poor discharge planning.46 In theory, MU should facili-
tate improvements in inpatient care and in transitions to the outpa-
tient setting,17,47 particularly in terms of communication and
coordination among providers, which is often lacking.48,49 There
was also no relationship between MU and our alternative outcome
measure of postsurgical mortality, suggesting that further work is
warranted to understand how MU may influence care quality both
in terms of inpatient care delivery and transitions of care.
We did, however, find that MU may be associated with lower in-
patient costs as assessed by Medicare inpatient payments. This may
occur through many mechanisms. For example, certified EHRs
may help providers adhere to evidence-based guidelines,50,51 which
may reduce the risk of major complications and, hence, lower costs.
Certified EHRs may enhance the quality of documentation of pa-
tient information and coordination among providers,17 which may
prevent costly redundancies in care.52,53 MU provides better tools
for complex tasks under Stage 2, including those to improve clinical
management in the inpatient setting and along the care continuum,
which may improve efficiency.54,55 On the other hand, it is also pos-
sible that having EHRs facilitates the capture and coding of a higher
number of comorbidities among hospitalized patients; this would
lead to an artificial reduction in risk-adjusted costs. A similar phe-
nomenon has been reported in the readmissions literature, where
higher coding of comorbidities over time has been shown to explain
some of the observed drop in risk-adjusted readmissions.56 Further
study to elucidate these potential mechanisms is important.
Our study should be taken in context with prior work. For in-
stance, a recent study examining the relationship between participa-
tion in value-based initiatives, including MU, and performance
on readmissions for conditions targeted under the Hospital
Readmissions Reduction Program (HRRP) demonstrated lower
risk-standardized 30-day readmission rates for acute myocardial in-
farction, pneumonia, and heart failure among hospitals with greater
value-based initiative participation.57 Likewise, a single-state analy-
sis comparing length of stay and readmission outcomes for Medicare
and non-Medicare patients treated at MU Stage 1 hospitals to those
observed at hospitals with partial- and full-EHR adoption found fa-
vorable outcomes for the former.58 Relatedly, other work reported
improvements in provider performance on processes of care associ-
ated with increased use of certified EHRs.50
There are policy implications for our findings. MU was designed
to accelerate widespread adoption and MU of certified EHR tech-
nology to improve care quality and reduce costs.13,19 Since the pro-
gram’s introduction in 2011, EHR uptake among hospitals is on the
rise.21,23 However, there are huge costs associated with implement-
ing, maintaining, and upgrading EHRs.59 Our findings suggest that
additional policy interventions beyond MU, as currently designed,
may be needed to drive improvements in the value of care delivered
and received under Medicare. As CMS contemplates potential
changes to MU—now renamed as the Promoting Interoperability
Programs—60 it may be important to consider how future require-
ments might incent both quality and cost improvement.
Our study has limitations. First, using a cross-sectional design,
we cannot ascribe a causal interpretation to our findings. Despite
the use of propensity score-based methods, and additional adjust-
ments for key covariates, it is possible that there are important
unmeasured differences between hospitals—be it leadership or other
factors—that elect to pursue MU and those that do not that may
bias our results. It is also possible that other concurrent value-based
payment efforts, such as bundled payments, accountable care organ-
izations, or the HRRP influenced our findings. Second, we only eval-
uated the Medicare component of the MU Program: Data on the
Medicaid component are not publically available. Therefore, we do
not know whether similar trends can be observed in the larger co-
hort of hospitals receiving EHR incentives under both components.
Third, we examined a stylized concept of value: We chose to evalu-
ate readmission and inpatient spending because of their broad and
complementary nature in terms of patient populations and their use
in public reporting and many current value-based payment pro-
grams. However, the concept of value is at present a somewhat fluid
one, and our results may not generalize to value defined differently.
Fourth, we only evaluated duration of participation. Hence, we do
not know the degree to which a hospital’s EHR use predated their
MU attestation nor whether a hospital attests early, drops out, and
then attests late. Two hospitals with similar MU data might have
very different EHR maturation phases (eg, 1 had the EHR for many
years, but another implemented it 1 year before MU). Finally, we
did not examine specific EHR functionalities. Pinpointing the under-
lying functionalities involved in quality and cost improvement may
be an important next step to ensure technology continues to drive
towards value.61,62 Finally, we did not examine vendor chosen by
hospitals. A recent study reported differential trends in hospital per-
formance on the attainment of 6 MU Stage 2 measures related to
vendor choice.63
CONCLUSION
A longer duration of participation in MU was not associated with
higher odds of achieving value—that is, good outcomes at low costs.
However, we did find that hospitals with longer MU participation
had lower inpatient costs. For EHRs to drive improvements in value,
changes to the MU programs, or other policy efforts focusing on
how these technologies can best be used to drive improvements in
quality, may be needed.
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